Encontrados 2 documentos, a visualizar página 1 de 1

Ordenado por Data

Mucopolysaccharidosis I, II, and VI: brief review and guidelines for treatment

Giugliani,Roberto; Federhen,Andressa; Muñoz Rojas,Maria Verônica; Vieira,Taiane; Artigalás,Osvaldo; Lapagesse Pinto,Louise; Azevedo,Ana Cecília

Mucopolysaccharidoses (MPS) are rare genetic diseases caused by the deficiency of one of the lysosomal enzymes involved in the glycosaminoglycan (GAG) breakdown pathway. This metabolic block leads to the accumulation of GAG in various organs and tissues of the affected patients, resulting in a multisystemic clinical picture, sometimes including cognitive impairment. Until the beginning of the XXI century, treat...

Data: 2010   |   Origem: Oasisbr

Pilot study with a glutamine-supplemented enteral formula in critically ill inf...

Barbosa,Eliana; Moreira,Emília A.M.; Goes,José Eduardo; Faintuch,Joel

Seriously ill infants often display protein-calorie malnutrition due to the metabolic demands of sepsis and respiratory failure. Glutamine has been classified as a conditionally essential amino acid, with special usefulness in critical patients. Immunomodulation, gut protection, and prevention of protein depletion are mentioned among its positive effects in such circumstances. With the intent of evaluating the ...

Data: 1999   |   Origem: Oasisbr

2 Resultados

Texto Pesquisado

Refinar resultados

Autor





















Data



Tipo de Documento


Tipo de acesso


Recurso


Assunto